title: Caveolin-3 is involved in the protection of resveratrol against high-fat-diet-induced insulin resistance by promoting GLUT4 translocation to the plasma membrane in skeletal muscle of ovariectomized rats.
abstract: Insulin resistance is recognized as a common metabolic factor which predicts the future development of both type 2 diabetes and atherosclerotic disease. Resveratrol (RSV), an agonist of estrogen receptor (ER), is known to affect insulin sensitivity, but the mechanism is unclear. Evidence suggests that caveolin-3 (CAV-3), a member of the caveolin family, is involved in insulin-stimulated glucose uptake. Our recent work indicated that estrogen via ER improves glucose uptake by up-regulation of CAV-3 expression. Here, we investigated the role of CAV-3 in the effect of RSV on insulin resistance in skeletal muscle both in vivo and in vitro. The results demonstrated that RSV ameliorated high-fat-diet (HFD)-induced glucose intolerance and insulin resistance in ovariectomized rats. RSV elevated insulin-stimulated glucose uptake in isolated soleus muscle in vivo and in C2C12 myotubes in vitro by enhancing GLUT4 translocation to the plasma membrane rather than increasing GLUT4 protein expression. Through ERα-mediated transcription, RSV increased CAV-3 protein expression, which contributed to GLUT4 translocation. Moreover, after knockdown of CAV-3 gene, the effects of RSV on glucose uptake and the translocation of GLUT4 to the plasma membrane, as well as the association of CAV-3 and GLUT4 in the membrane, were significantly attenuated. Our findings demonstrated that RSV via ERα elevated CAV-3 expression and then enhanced GLUT4 translocation to the plasma membrane to promote glucose uptake in skeletal muscle, exerting its protective effects against HFD-induced insulin resistance. It suggests that this pathway could represent an effective therapeutic target to fight against insulin resistance syndrome induced by HFD.
authors.affiliation: Department of Physiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, PR China. tanzhi@mail.sysu.edu.cn
authors.forename: Zhi
authors.initials: Z
authors.lastname: Tan
authors.forename: Li-Jun
authors.initials: LJ
authors.lastname: Zhou
authors.forename: Pan-Wei
authors.initials: PW
authors.lastname: Mu
authors.forename: Shui-Ping
authors.initials: SP
authors.lastname: Liu
authors.forename: Si-Juan
authors.initials: SJ
authors.lastname: Chen
authors.forename: Xiao-Dong
authors.initials: XD
authors.lastname: Fu
authors.forename: Ting-Huai
authors.initials: TH
authors.lastname: Wang
mesh_terms: D000818:Animals; D051244:Caveolin 3 / Q000235:genetics / Q000378:metabolism*; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D059305:Diet, High-Fat / Q000009:adverse effects*; D047628:Estrogen Receptor alpha / Q000378:metabolism; D005260:Female; D005947:Glucose / Q000378:metabolism / Q000493:pharmacokinetics; D018149:Glucose Intolerance / Q000517:prevention & control; D051275:Glucose Transporter Type 4 / Q000378:metabolism*; D007328:Insulin / Q000494:pharmacology; D007333:Insulin Resistance; D018485:Muscle Fibers, Skeletal / Q000187:drug effects; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism*; D010052:Ovariectomy; D020011:Protective Agents / Q000494:pharmacology; D021381:Protein Transport / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology*
chemical_list: D051244:Caveolin 3; D047628:Estrogen Receptor alpha; D051275:Glucose Transporter Type 4; D007328:Insulin; D020011:Protective Agents; C495694:Slc2a4 protein, rat; D013267:Stilbenes; D005947:Glucose; D000077185:Resveratrol